Not Medicare Enrolled

Dr. Alberto Choy, M.D.

Pulmonary Disease · Jupiter, FL
Speaking/Promotional
500 UNIVERSITY BLVD, Jupiter, FL 33458
5616273336
In practice since 2006 (19 years)
NPI: 1639113350 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Choy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Choy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Choy

Dr. Alberto Choy is a pulmonary disease in Jupiter, FL, with 19 years in practice.

Between the years covered by Open Payments, Dr. Choy received a total of $8,014 from 22 pharmaceutical and/or device companies across 170 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Choy is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $8,014 industry payments

Industry Payment Transparency

Open Payments through 2021 ↗
$8,014
Total received (2018-2021)
Avg $2,004/year across 4 years
Top 26% in FL for pulmonary disease
22
Companies
170
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,990 (62.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,024 (37.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2021
$31
2020
$4,914
2019
$637
2018
$2,433

Payments by company (2021)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$5,728
Boehringer Ingelheim Pharmaceuticals, Inc.
$763
AstraZeneca Pharmaceuticals LP
$281
Genentech USA, Inc.
$151
Sunovion Pharmaceuticals Inc.
$151
Mallinckrodt LLC
$142
Allergan Inc.
$120
Actelion Pharmaceuticals US, Inc.
$91
E.R. Squibb & Sons, L.L.C.
$83
Circassia Pharmaceuticals Inc
$82
Shire North American Group Inc
$73
Lilly USA, LLC
$68
Novartis Pharmaceuticals Corporation
$59
Gilead Sciences, Inc.
$46
Grifols USA, LLC
$37
Bayer HealthCare Pharmaceuticals Inc.
$33
Mylan Specialty L.P.
$24
Advanced Respiratory, Inc
$24
Electromed, Inc.
$19
Insmed, Inc.
$16
PFIZER INC.
$15
United Therapeutics Corporation
$8
Top 3 companies account for 84.5% of total payments
Associated products mentioned in payments ›
ACTHAR · ANORO · ANORO ELLIPTA · AVYCAZ · Adempas · BREO · BREZTRI · BROVANA · CALQUENCE · CHANTIX · CUVITRU · CYRAMZA · Dymista · Esbriet · FASENRA · GAMMAGARD · GILOTRIF · HYQVIA · IMFINZI · LONHALA MAGNAIR · MEKINIST · NUCALA · OFEV · OPDIVO · OPSUMIT MACITENTAN · ORENITRAM · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UTIBRON · Utibron · XOLAIR · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (62%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware.

Looking for a pulmonary disease in Jupiter?
Compare pulmonary diseases in the Jupiter area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
28
Per 100K population
1.9
County median income
$81,115
Nearest hospital
JUPITER MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2021
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Choy is a pulmonary disease, and speaking/promotional industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Choy receive payments from pharmaceutical companies?
Yes. Dr. Choy received a total of $8,014 from 22 companies across 170 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Choy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Jupiter
Browse pulmonary diseases in Jupiter ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC..
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →